pembrolizumab,vibostolimab,favezelimab
merck
['mibc', 'pembro', 'favezelimab', 'key,note,57', 'nmibc', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'vibostolimab', 'imab ']
phase 2 #keynote057 cohort c: pembrolizumab with vibostolimab or favezelimab for pts with high-risk bcg-unresponsive #nmibc. presented by neal d. shore, md, facs . #gu23 written coverage by &gt; 
Largest global online community of #urological medical professionals & patients. #bladdercancer #menshealth #prostatecancer #kidneycancer #Urology